• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Diabetes linked to increased mortality in China

byAdarsh ManjunathandMichael Milligan
January 20, 2017
in Chronic Disease, Endocrinology, Public Health
Reading Time: 2 mins read
Intrapartum serum prolactin may predict risk of postpartum diabetes
Share on FacebookShare on Twitter

1. In a 7-year nationwide prospective study of over a half-million Chinese adults, diabetes was more common in urban than rural areas.

2. Diabetes was linked to increased mortality due to ischemic heart disease, stroke, chronic liver disease, and infections.

Evidence Rating Level: 2 (Good)

Study Rundown: Diabetes remains one of the most common chronic medical conditions in the United States. In China, the prevalence of diabetes has more than quadrupled in recent decades. The impact of diabetes on morbidity and mortality in China is unknown, and the authors of this study sought out to perform a nationwide prospective study to determine the association between diabetes and cause-specific mortality in rural and urban areas in China. Among more than 500,000 people who responded to study questionnaires, 5.9% of people had diabetes. Individuals with diabetes had twice the risk of all-cause mortality compared to individuals without diabetes. Furthermore, this risk was increased for people in rural areas than those in urban areas. People with diabetes also had at least twice the increased risk of mortality due to ischemic heart disease, stroke, chronic liver disease, and infections.

Overall, this study suggests that diabetes is associated with increased overall mortality and specifically with mortality due to a number of cardiovascular and non-cardiovascular diseases. A major limitation of this study is that diabetes prevalence was estimated using random plasma glucose and fasting plasma glucose, not hemoglobin A1c or 2-hour glucose measurements. Additionally the prevalence of type I diabetes in this population was unknown which may serve to confound the results.

Click to read the study in JAMA

RELATED REPORTS

Duodenal-jejunal bypass liners may improve glycemic control in patients with diabetes

Telehealth yields modest improvements in diabetes outcomes 

Tirzepatide improves blood sugar control in metformin-refractory type 2 diabetes

Relevant Reading: Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults

In-Depth [prospective cohort]: This study utilized the China Kadoorie Biobank, which consisted of baseline surveys from 2004-2008 across 10 localities in urban and rural China. Participants included 512,869 residents aged 35-74 years for whom health histories and labs were obtained. These people were followed up until 2014. At baseline, 5.9% of people had diabetes, of which 2.8% was detected by screening. Diabetics were more likely to be less physically active and have higher body mass index, blood pressure, and history of hypertension, cardiovascular disease, and chronic kidney disease. The prevalence of diabetes was higher in urban areas at 8.1% compared to rural areas at 4.1%. With 3.64 million person-years of follow-up, a total of 24,909 people died, 3,384 of whom had been diagnosed with diabetes. People with diabetes had twice the increased risk of all-cause mortality compared to individuals without diabetes (1,373 vs 646 deaths per 100,000; RR 2.00 [CI95% 1.93-2.08]). Interestingly, this risk was greater in rural areas (RR 2.17 [CI95% 2.07-2.29]) than in urban areas (RR 1.83 [CI95% 1.73-1.94]). Furthermore, diabetes was associated with increased mortality due to a number of cardiovascular and non-cardiovascular diseases- specifically, ischemic heart disease (RR 2.40 [CI95% 2.19-2.63]), stroke (RR 1.98 [CI95% 1.81-2.17]), chronic liver disease (RR 2.32 [CI95% 1.76-3.06]), and infections (RR 2.29 [CI95% 1.76-2.99]).

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chinadiabetes mellitus
Previous Post

Ocrelizumab decreases multiple sclerosis relapse rate compared to interferon beta-1a

Next Post

AAP reaffirms support for adolescents’ rights to confidential reproductive care

RelatedReports

Surgery

Duodenal-jejunal bypass liners may improve glycemic control in patients with diabetes

July 16, 2026
Chronic Disease

Telehealth yields modest improvements in diabetes outcomes 

June 22, 2026
Food environment associated with gestational diabetes
Chronic Disease

Tirzepatide improves blood sugar control in metformin-refractory type 2 diabetes

May 25, 2026
Intrapartum serum prolactin may predict risk of postpartum diabetes
Chronic Disease

Dipeptidyl peptidase-4 inhibitors may be associated with an increased incidence of malignancy

March 26, 2026
Next Post
AAP reaffirms support for adolescents’ rights to confidential reproductive care

AAP reaffirms support for adolescents’ rights to confidential reproductive care

Reduced HPV vaccine doses may be adequate

2 Minute Medicine Rewind January 23, 2017

CPAP may not decrease cardiovascular events in sleep apnea

Home and lab sleep study data may be similar for use in management of obstructive sleep apnea

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality
  • Alcohol use declines but remains above pre-pandemic levels
  • High maternal egg-peanut intake not associated with reduced infant allergy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.